Microbiology

  1. Several FDA-approved drugs effectively inhibit SARS-CoV-2 infection in vitro

    1. Hua-Long Xiong
    2. Jia-Li Cao
    3. Chen-Guang Shen
    4. Jian Ma
    5. Xiao-Yang Qiao
    6. Tian-Shu Shi
    7. Yang Yang
    8. Sheng-Xiang Ge
    9. Jun Zhang
    10. Tian-Ying Zhang
    11. Quan Yuan
    12. Ning-Shao Xia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. The Zinc Finger Antiviral Protein restricts SARS-CoV-2

    1. Rayhane Nchioua
    2. Dorota Kmiec
    3. Janis Müller
    4. Carina Conzelmann
    5. Rüdiger Groß
    6. Chad Swanson
    7. Stuart Neil
    8. Steffen Stenger
    9. Daniel Sauter
    10. Jan Münch
    11. Konstantin M. J. Sparrer
    12. Frank Kirchhoff

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Integrated genomic view of SARS-CoV-2 in India

    1. Pramod Kumar
    2. Rajesh Pandey
    3. Pooja Sharma
    4. Mahesh S Dhar
    5. A Vivekanand
    6. Bharathram Uppili
    7. Himanshu Vashisht
    8. Saruchi Wadhwa
    9. Nishu Tyagi
    10. Saman Fatihi
    11. Uma Sharma
    12. Priyanka Singh
    13. Hemlata Lall
    14. Meena Datta
    15. Poonam Gupta
    16. Nidhi Saini
    17. Aarti Tewari
    18. Bibhash Nandi
    19. Dhirendra Kumar
    20. Satyabrata Bag
    21. Deepanshi
    22. Surabhi Rathore
    23. Nidhi Jatana
    24. Varun Jaiswal
    25. Hema Gogia
    26. Preeti Madan
    27. Simrita Singh
    28. Prateek Singh
    29. Debasis Dash
    30. Manju Bala
    31. Sandhya Kabra
    32. Sujeet Singh
    33. Mitali Mukerji
    34. Lipi Thukral
    35. Mohammed Faruq
    36. Anurag Agrawal
    37. Partha Rakshit

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Rapid detection of SARS-CoV-2 and other respiratory viruses by using LAMP method with Nanopore Flongle workflow

    1. Jingjing Li
    2. Weipeng Quan
    3. Shuge Yan
    4. Shuangju Wu
    5. Jianhu Qin
    6. Tingting Yang
    7. Fan Liang
    8. Depeng Wang
    9. Yu Liang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. In Silico design and characterization of multi-epitopes vaccine for SARS-CoV2 from its spike proteins

    1. Gunderao H Kathwate

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain

    1. Simona Iftimie
    2. Ana F. López-Azcona
    3. Manuel Vicente-Miralles
    4. Ramon Descarrega-Reina
    5. Anna Hernández-Aguilera
    6. Francesc Riu
    7. Josep M. Simó
    8. Pedro Garrido
    9. Jorge Joven
    10. Jordi Camps
    11. Antoni Castro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Optimized pseudotyping conditions for the SARS-COV2 Spike glycoprotein

    1. Marc C. Johnson
    2. Terri D. Lyddon
    3. Reinier Suarez
    4. Braxton Salcedo
    5. Mary LePique
    6. Maddie Graham
    7. Clifton Ricana
    8. Carolyn Robinson
    9. Detlef G. Ritter

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients

    1. Cristina Andres
    2. Damir Garcia-Cehic
    3. Josep Gregori
    4. Maria Piñana
    5. Francisco Rodriguez-Frias
    6. Mercedes Guerrero-Murillo
    7. Juliana Esperalba
    8. Ariadna Rando
    9. Lidia Goterris
    10. Maria Gema Codina
    11. Susanna Quer
    12. Maria Carmen Martín
    13. Magda Campins
    14. Ricard Ferrer
    15. Benito Almirante
    16. Juan Ignacio Esteban
    17. Tomás Pumarola
    18. Andrés Antón
    19. Josep Quer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

    1. Leo Hanke
    2. Laura Vidakovics Perez
    3. Daniel J. Sheward
    4. Hrishikesh Das
    5. Tim Schulte
    6. Ainhoa Moliner-Morro
    7. Martin Corcoran
    8. Adnane Achour
    9. Gunilla B. Karlsson Hedestam
    10. B. Martin Hällberg
    11. Ben Murrell
    12. Gerald M. McInerney

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. A Scalable Topical Vectored Vaccine Candidate Against SARS-CoV-2

    1. Mohammed A Rohaim
    2. Muhammad Munir

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 59 of 251 Next